The National Heritage Insurance Company, a Medicare contractor, has decided to cover Genomic Health’s Oncotype Dx test — a move that could guide the course of reimbursement decisions for future pharmacogenomic diagnostics.
The National Heritage Insurance Company, a Medicare contractor, has decided to cover Genomic Health’s Oncotype Dx test — a move that could guide the course of reimbursement decisions for future pharmacogenomic diagnostics.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.